Drug Development

• USask researchers to start clinical trials for new Alzheimer’s drug

  NeuroEPO, a drug studied in early Alzheimer's patients, is being advanced. The USask team is working with Saskatoon organizations to recruit participants.

  Health

  Feb 9, 2023
  
• Scientists hope to link lab bench with pharmacy shelves through Edmonton drug plant

  The Alberta effort would be unique in linking the latest scientific insights from the lab to the drugstore shelf, as well as in the type and breadth of drugs it would help develop.

  Science

  Nov 1, 2021
  
• Advertisement
• COVID-19 would have been worse without recent advances in science

  The world was 100% more prepared for COVID-19 than it was for the flu 100 years ago, Dr. David Pride says.

  Commentary

  Dec 20, 2020
• Advertisement
• How COVID-19 vaccines are being tested in clinical trials

  But what is a Phase 3 clinical study? Charles Weijer, professor at Western University, explains.

  Commentary

  Sep 27, 2020
• ‘Vaccine nationalism’ could threaten Canada’s access to a COVID-19 vaccine

  Canada must do more to ensure it has access to the drugs, including any potential vaccine, needed in the battle against COVID-19, says Joel Lexchin of York University.

  Commentary

  Jul 12, 2020